Although the traditional enzyme-linked immunosorbent
assay (ELISA)
has been widely applied in pathogen detection and clinical diagnostics,
it always suffers from complex procedures, a long incubation time,
unsatisfying sensitivity, and a single signal readout. Here, we developed
a simple, rapid, and ultrasensitive platform for dual-mode pathogen
detection based on a multifunctional nanoprobe integrated with a capillary
ELISA (CLISA) platform. The novel capture antibodies-modified capillaries
can act as a swab to combine in situ trace sampling and detection
procedures, eliminating the dissociation between sampling and detection
in traditional ELISA assays. With excellent photothermal and peroxidase-like
activity, the Fe3O4@MoS2 nanoprobe
with a unique p–n heterojunction was chosen as an enzyme substitute
and amplified signal tag to label the detection antibody for further
sandwich immune sensing. As the analyte concentration increased, the
Fe3O4@MoS2 probe could generate dual-mode
signals, including remarkable color changes from the chromogenic substrate
oxidation as well as photothermal enhancement. Moreover, to avoid
false negative results, the excellent magnetic capability of the Fe3O4@MoS2 probe can be used to pre-enrich
the trace analytes, amplifying the detection signal and enhancing
the immunoassay’s sensitivity. Under optimal conditions, specific
and rapid detection of SARS-CoV-2 has been realized
successfully based on this integrated nanoprobe-enhanced CLISA platform.
The detection limits were 5.41 pg·mL–1 for
the photothermal assay and 150 pg·mL–1 for
the visual colorimetric assay. More importantly, the simple, affordable,
and portable platform can also be expanded to rapidly detect other
targets such as Staphylococcus aureus and Salmonella typhimurium in practical
samples, making it a universal and attractive tool for multiple pathogen
analysis and clinical testing in the post COVID-19 era.